Plasma homocysteine in the acute and convalescent phases after stroke.
Explore this paper's citation graph
Summary
The post-acute-phase increase in plasma homocysteine may explain why higher values were obtained for stroke patients than for control subjects in previous studies.
- Type
- article
- Published
- 1995-05-01
- Cited by
- 239
- References
- 30
- OpenAlex
- https://openalex.org/W2051645764
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:38233979
Keywords
Medicine, Stroke (engine), Plasma homocysteine, Acute stroke, Cardiology
References
- Total plasma homocysteine determination in subjects with premature cerebral vascular disease.
- Fundamentals of Clinical Chemistry
- The utilization of N-acetylcysteine and 2-oxothiazolidine-4-carboxylate by rat hepatocytes is limited by their rate of uptake and conversion to cysteine.
- Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization.
- Plasma homocyst(e)ine as a risk factor for early familial coronary artery disease.
- Comparison of Clinical and Neuroradiological Findings in First‐Ever Stroke: A Population‐Based Study
- Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
- Atherosclerotic Cardiovascular Disease, Hemostasis and Endothelial Function
- Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.
- Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
- Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
- Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects.
- Glutathione metabolism in activated human neutrophils: stimulation of glutathione synthesis and consumption of glutathione by reactive oxygen species
- Carotid artery intimal-medial wall thickening and plasma homocyst(e)ine in asymptomatic adults. The Atherosclerosis Risk in Communities Study.
- Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease.
- Homocysteine and cysteine: determinants of plasma levels in middle‐aged and elderly subjects
- Plasma homocysteine before and after methionine loading with regard to age, gender, and menopausal status
- Classification and natural history of clinically identifiable subtypes of cerebral infarction.
- Disordered methionine/homocysteine metabolism in premature vascular disease. Its occurrence, cofactor therapy, and enzymology.
- The pathogenesis of homocysteinemia: interruption of the coordinate regulation by S-adenosylmethionine of the remethylation and transsulfuration of homocysteine.
Cited by
- Homozygosity for the C 677 →T mutation of 5,10‐methylenetetrahydrofolate reductase and total plasma homocyst(e)ine are not associated with greater than normal risk of a first myocardial infarction in northern Sweden
- Tissue Factor and Homocysteine Levels in Ischemic Heart Disease Are Associated with Angiographically Documented Clinical Recurrences after Coronary Angioplasty
- Animal models of diet-induced atherosclerosis.
- Homocysteine in cardiovascular disease with special reference to longitudinal changes
- Hiperhomocisteinemia y ateromatosis coronaria: estudio epidemiológico en un grupo de población de enfermos de la provincia de Santa Cruz de Tenerife
- Management of spontaneous dissection of the cervical carotid artery.
- Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis.
- Total plasma homocysteine level and risk of cardiovascular disease: a meta-analysis of prospective cohort studies.
- Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial.
- The serial changes in plasma homocysteine levels and it's relationship with acute phase reactants in early postmyocardial infarction period.
- Focus on Homocysteine and the Vitamins
- Serial Changes in Markers Measuring Coagulation, Fibrinolysis, and Vasoactivity in Patients with Ischemic Stroke
- The VITATOPS (Vitamins to Prevent Stroke) Trial: Rationale and Design of an International, Large, Simple, Randomised Trial of Homocysteine-Lowering Multivitamin Therapy in Patients with Recent Transient Ischaemic Attack or Stroke
- Homocysteine as a risk factor for cardiovascular disease: should we (still) worry about?
- Homocysteina jako czynnik ryzyka uszkodzenia naczyń
- Hemostatic Risk Factors and Arterial Thrombotic Disease
- Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease.
- Thrombophilien bei Patienten mit ischämischem Schlaganfall
- Un factor aterogénico no convencional: la homocisteina
- Hiperhomocisteinemia, polimorfismos genéticos y síndrome coronario agudo
Related papers
- Relationship between plasma homocysteine level in pregnant women and premature delivery
- Lipid-lowering drugs and homocysteine. A comparison between statins and other lipid-lowering drugs.
- The Significance of Plasma Homocysteine Level in Pregnant Women with Severe Preeclampsia
- Relationship between the early renal injury in type 2 diabetes patients and the plasma homocysteine concentration
- The effect study of Ganyanping on plasma homocysteine on CCl_4 induced liver fibrosis in rats
- Homocysteine level in CAD patients of Iranian population
- The Relationship between Plasma Homocysteine Concentration and the Ischemic Stroke in Young and Middle-aged Adults
- Effect of methionine loading on 5-methyltetrahydrofolate, S-adenosylmethionine and S-adenosylhomocysteine in plasma of healthy humans.
- Serum Homocysteine Levels in Children
- Betaine supplementation decreases plasma homocysteine in healthy adult participants: a meta-analysis.